Nothing Special   »   [go: up one dir, main page]

IL87746A - Pharmaceutical compositions containing pharmacologically active compounds and water soluble monoesters as solubilisers therefor - Google Patents

Pharmaceutical compositions containing pharmacologically active compounds and water soluble monoesters as solubilisers therefor

Info

Publication number
IL87746A
IL87746A IL87746A IL8774688A IL87746A IL 87746 A IL87746 A IL 87746A IL 87746 A IL87746 A IL 87746A IL 8774688 A IL8774688 A IL 8774688A IL 87746 A IL87746 A IL 87746A
Authority
IL
Israel
Prior art keywords
solubilisers
therefor
pharmaceutical compositions
water soluble
active compounds
Prior art date
Application number
IL87746A
Other versions
IL87746A0 (en
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IL87746A0 publication Critical patent/IL87746A0/en
Publication of IL87746A publication Critical patent/IL87746A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL87746A 1987-09-15 1988-09-14 Pharmaceutical compositions containing pharmacologically active compounds and water soluble monoesters as solubilisers therefor IL87746A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3730909 1987-09-15
DE3802355 1988-01-27

Publications (2)

Publication Number Publication Date
IL87746A0 IL87746A0 (en) 1989-02-28
IL87746A true IL87746A (en) 1992-07-15

Family

ID=25859774

Family Applications (1)

Application Number Title Priority Date Filing Date
IL87746A IL87746A (en) 1987-09-15 1988-09-14 Pharmaceutical compositions containing pharmacologically active compounds and water soluble monoesters as solubilisers therefor

Country Status (24)

Country Link
JP (1) JP3090666B2 (en)
KR (1) KR0131084B1 (en)
AT (1) AT395819B (en)
AU (1) AU628787B2 (en)
BE (1) BE1001204A5 (en)
CA (1) CA1338775C (en)
CH (1) CH683672A5 (en)
DK (1) DK175132B1 (en)
ES (1) ES2012118A6 (en)
FI (1) FI94837C (en)
FR (1) FR2620336B1 (en)
GB (1) GB2209671B (en)
GR (1) GR1002243B (en)
HU (1) HU205010B (en)
IE (1) IE61195B1 (en)
IL (1) IL87746A (en)
IT (1) IT1224886B (en)
LU (1) LU87335A1 (en)
MY (1) MY103769A (en)
NL (1) NL195094C (en)
NO (1) NO179434C (en)
NZ (1) NZ226163A (en)
PT (1) PT88492B (en)
SE (1) SE503279C2 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
KR0148748B1 (en) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 A multiphase cyclosporin composition
GR1000466B (en) * 1989-01-28 1992-07-30 Sandoz Ag Preparation method of novel pharmaceutical forms of cyclosporine
GB2230440B (en) * 1989-02-09 1993-05-19 Sandoz Ltd Novel cyclosporin galenic forms
GB8916901D0 (en) 1989-07-24 1989-09-06 Sandoz Ltd Improvements in or relating to organic compounds
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
ES2098739T3 (en) 1992-05-13 1997-05-01 Sandoz Ltd OPHTHALMIC COMPOSITIONS CONTAINING A CYCLOSPORIN.
EP0589843B1 (en) 1992-09-25 2001-11-28 Novartis AG Pharmaceutical compositions containing cyclosporins
DE69426408T2 (en) 1993-09-28 2001-07-12 Novartis Ag, Basel Manufacture of soft gelatin capsules
ATE218359T1 (en) 1994-11-03 2002-06-15 Novartis Erfind Verwalt Gmbh NEW PREPARATION FORMS OF CYCLOSPORIN FOR ORAL APPLICATION WITH SIMPLE COMPOSITION AND HIGH BIOAVAILABILITY AND METHOD FOR THE PRODUCTION THEREOF
US5834017A (en) * 1995-08-25 1998-11-10 Sangstat Medical Corporation Oral cyclopsporin formulations
US5766629A (en) 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
US5827822A (en) * 1996-03-25 1998-10-27 Sangstat Medical Corporation Cyclosporin a formulations as nanoparticles
DE19544507B4 (en) 1995-11-29 2007-11-15 Novartis Ag Cyclosporin containing preparations
TW414696B (en) * 1996-07-01 2000-12-11 Mitsubishi Kagaku Foods Kk Anti-bacteria agent
CA2278675A1 (en) 1997-01-30 1998-08-06 Novartis Ag Hard gelatine capsules containing pharmaceutical compositions substantially free of any oil
GB2326337A (en) * 1997-06-20 1998-12-23 Phares Pharma Holland Homogeneous lipid compositions for drug delivery
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
EP1558215A4 (en) * 2003-10-14 2007-09-12 Wockhardt Ltd Sterile gelling agents
JP5422871B2 (en) * 2006-10-24 2014-02-19 不二製油株式会社 Isoflavones composition

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE624258A (en) * 1961-10-31
GB1134878A (en) * 1966-05-12 1968-11-27 Suga Kazuo Improvements in and relating to oryzanol solutions and compositions
FR5986M (en) * 1966-11-22 1968-06-21
BE787842A (en) * 1971-08-25 1972-12-18 Sumito Chemical Cy Ltd PROCESS FOR PREPARING AN AQUEOUS SUSPENSION OF STABLE CRYSTALS OF THE NON-BETA TYPE OF HIGHER FATTY ACID ESTERS OF CHLORAMPHENICOL
JPS53107408A (en) * 1977-02-28 1978-09-19 Yamanouchi Pharmaceut Co Ltd Micellar preparation for rectal infusion
DE2907460A1 (en) * 1978-03-07 1979-09-13 Sandoz Ag NEW RESORBABLE GALENIC COMPOSITIONS
JPS57128634A (en) * 1981-02-03 1982-08-10 Eisai Co Ltd Elastase-containing compound increasing absorption
EP0179583A1 (en) * 1984-10-04 1986-04-30 Merck & Co. Inc. A system for enhancing the water dissolution rate and solubility of poorly soluble drugs
JPS61280435A (en) * 1985-04-04 1986-12-11 Kanji Takada Lymph orienting preparation of cyclosporin

Also Published As

Publication number Publication date
JP3090666B2 (en) 2000-09-25
FR2620336A1 (en) 1989-03-17
CH683672A5 (en) 1994-04-29
HU205010B (en) 1992-03-30
BE1001204A5 (en) 1989-08-16
GR1002243B (en) 1996-04-22
AT395819B (en) 1993-03-25
GB8821443D0 (en) 1988-10-12
KR890004694A (en) 1989-05-09
DK511188A (en) 1989-03-16
FR2620336B1 (en) 1991-10-25
GR880100602A (en) 1989-06-22
NO884052D0 (en) 1988-09-13
ATA224988A (en) 1992-08-15
NO179434B (en) 1996-07-01
PT88492B (en) 1993-03-31
SE503279C2 (en) 1996-05-13
NL195094C (en) 2003-12-17
SE8803221D0 (en) 1988-09-13
IT1224886B (en) 1990-10-24
CA1338775C (en) 1996-12-10
KR0131084B1 (en) 1998-04-17
AU628787B2 (en) 1992-09-24
MY103769A (en) 1993-09-30
GB2209671B (en) 1991-11-13
LU87335A1 (en) 1989-04-06
DK175132B1 (en) 2004-06-14
HUT49494A (en) 1989-10-30
NZ226163A (en) 1991-08-27
JPH01151526A (en) 1989-06-14
IE61195B1 (en) 1994-10-19
IL87746A0 (en) 1989-02-28
FI94837B (en) 1995-07-31
PT88492A (en) 1988-10-01
FI94837C (en) 1995-11-10
NL8802275A (en) 1989-04-03
FI884192A (en) 1989-03-16
NO884052L (en) 1989-03-16
ES2012118A6 (en) 1990-03-01
IE882772L (en) 1989-03-15
AU2217288A (en) 1989-04-27
DK511188D0 (en) 1988-09-14
GB2209671A (en) 1989-05-24
FI884192A0 (en) 1988-09-13
SE8803221L (en) 1989-03-16
NO179434C (en) 1996-10-09
IT8848349A0 (en) 1988-09-14

Similar Documents

Publication Publication Date Title
IL87746A (en) Pharmaceutical compositions containing pharmacologically active compounds and water soluble monoesters as solubilisers therefor
NZ219274A (en) Indolizine derivatives and pharmaceutical compositions
ZA872067B (en) Vaginal pharmaceutical composition
NZ222373A (en) Antihypertensive agents and pharmaceutical compositions containing nor-statine and cyclostatine
NZ220880A (en) Di-tert-butyl-phenol derivatives and pharmaceutical compositions
PH24909A (en) Imidazopyridine derivatives and pharmaceutical compositions
KR950013762B1 (en) Pharmaceutical compositions having antineoplastic activity
NZ220171A (en) Dihydro-benzopyran derivatives and pharmaceutical compositions
NZ221843A (en) Cephem compounds and pharmaceutical compositions
NZ226002A (en) Peptidylheterocyclic compounds and pharmaceutical compositions
GB8818447D0 (en) Tripeptides & pharmaceutical compositions containing them
NZ222116A (en) 3-propenylcephem derivatives and pharmaceutical compositions; processes for preparation
NZ222670A (en) Cephalosporin derivatives and pharmaceutical compositions
PH24227A (en) Sustained released pharmaceutical compositions
IL87494A0 (en) Pharmaceutical compositions containing benzylpyrimidine derivatives
NZ224923A (en) 2-methoxymethyl-penem-3-carboxylic acid derivatives and pharmaceutical compositions
NZ223051A (en) Carbamoyloxylabdane derivatives and pharmaceutical compositions
NZ220541A (en) Tetrazole derivatives and pharmaceutical compositions
NZ221018A (en) 2-penem-3-carboxylic acid derivatives and pharmaceutical compositions
NZ221549A (en) Penicillin derivatives & pharmaceutical compositions
IL94937A0 (en) Pharmaceutical compositions containing acrylic acid derivatives
IL84857A0 (en) Pharmaceutical compositions containing certain pyranoquinoline derivatives
NZ220383A (en) Pyrroloisoquinoline derivatives and pharmaceutical compositions
ZA886885B (en) Water soluble monoesters as solubilisers for pharmacologically active compounds and pharmaceutical excipients
ZA877502B (en) Pharmaceutical compositions having antineoplastic activity

Legal Events

Date Code Title Description
HC Change of name of proprietor(s)
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXTN Extension order renewed